Analysts cut ratings and price targets on US-listed companies
Reuters reports that Wall Street analysts lowered ratings and price targets on several US-listed companies, including Amgen, CarMax and Pfizer.
Reuters reports that Wall Street analysts lowered ratings and price targets on several US-listed companies, including Amgen, CarMax and Pfizer.